B0B8N8 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeichy6vxjw4vbcru22nbgu35pt6egcm2lf6yaenmmd37dkrrygx33q/metadata.json
IPFS of structure file: 
bafybeico5d3xnabxao3yu4xxdcudlch3u3xgfchdkuewpcsh2543z5zyx4/AF-B0B8N8-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xBE81563aE073ce9CCBbFCd4eb1F3935F14a0001F
First NFT owner address (bech32): 
genesis1h6q4vwhqw08fejale48truuntu22qqqlfyjfyf
Current NFT ID #166536 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166536
Accession (UniProt):
B0B8N8
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
CHLAMYDIA TRACHOMATIS SEROVAR L2 (STRAIN 434/BU / ATCC VR-902B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0B8N8 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0B8N8|HEM1_CHLT2 Glutamyl-tRNA reductase OS=Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) OX=471472 GN=hemA PE=3 SV=1 MVREGEERIGNRVLLGVIGVSYRETTLQQREQVLHILQQAQGSFRPEVFQEERDYVLLATCHRVELYSVAPAELFDSLAQEIKLLGVSPYFYRNQDCFAHLFCVAGGLDSLVLGETEIQGQVKRAYLQAAREQKLSFALHFLFQKALKEGKVFRAKGGAPYAAITIPILVDQELRRRQIDKKASLLFIGYSEINRSVAYHLRRQGFSCITFCSRQQLPTLSMRQVVREELCFQDPYRVVFLGSLELQYALPHSLWESIWDIPDRIVFDFAVPRALPSHTVFPHRYMDMDQISDWLREHRKEVNSAHLDSLREVAYRYWNSLNQRLERHDCVGANA